Large pharma focus ArcheMedX already serves 21 of the top 25 pharmaceutical firms along with emerging biotechs and global CROs, signaling strong potential for expansion within large pharma accounts and contract research organizations that demand scalable training and risk mitigation solutions.

Ready impact The Ready platform delivers measurable improvements in site readiness, training effectiveness, and trial risk mitigation with high adoption and renewals, creating a compelling value proposition for sponsors seeking faster trial activation and reduced cycle times.

Global reach With 250,000+ clinical professionals in over 90 countries using Ready, there is demonstrated capability to scale internationally, suggesting opportunities to upsell to multinational sponsors requiring standardized, cross-border training and performance analytics.

Data and analytics The emphasis on behavioral science, predictive analytics, and risk identification enables sales conversations around advanced insights, dashboards, and decision support, appealing to sponsors prioritizing data-driven trial optimization.

Expansion potential Upcoming features such as patient education modules and ongoing platform expansions present cross-sell opportunities to broaden the scope of training, including site and rater training, CRA oversight, and workforce development across sponsors' clinical programs.